Replies to post #8440 on Synaptogenix Inc (SNPX)

[Antti]

Good news. The enrollment pace also increased considerably in the end which is nice so see. It appears there were small scale rush to enter the study in the end and they got 108 patients instead of the target 100.

I guess some doctors saw some nice things and wanted their patients in before it was too late :). Now that the dosing is initiated we may get the results early September.

I also liked this part:

and to making continued progress in exploring Bryostatin's potential in other disease indications.